-
Underbelly launches The Big Brain Benefit
We’re thrilled to be partnering with live entertainment company Underbelly, who’ve chosen to support The Brain Tumour Charity at a number of iconic events.
-
Evolution Coaching becomes our longest standing partner
Evolution Coaching has provided The Brain Tumour Charity with exceptional pro bono leadership coaching and professional development training, totalling in excess of £50,000!
-
New breakthrough into Medulloblastoma
Researchers from St. Jude Children’s Research Hospital in the US and the German Cancer Research Centre have discovered faulty genes underlying medulloblastoma brain tumours.
-
Launching our Young Adult Service
Our new Young Adult Service aims to help young people aged 16-30 feel less isolated after devastating diagnosis
-
English Cancer Patient Experience Survey published
Earlier today, the English Cancer Patient Experience Survey was published, providing an insight into the experience of 72,288 cancer patients over the age of 16 in 2016
-
Tom Daley to front our BBC Lifeline appeal
Tom heads up The Charity’s drive to raise awareness and funds for vital research
-
The Samantha Dickson Brain Cancer Unit discover brain mechanism that could target future therapies
The group of researchers at UCL, funded by The Charity are led by Professor Paolo Salomoni and have discovered that cells are capable of migrating through tissues in the body
-
Ed Kerry’s epic challenge in memory of his sister
Inspired by his sister, Ed’s planning an epic, 1,000 mile UK running challenge
-
Researchers find that ultrasound may help get drugs across the blood-brain barrier
This promising technique was developed by Researchers from the University of Oxford, UK and the University of Twente, Netherlands
-
Welsh government publishes second Cancer Patient Experience Survey
Yesterday, Macmillan Wales and the Welsh Government published the second Wales Cancer Patient Experience Survey
-
Call for routine DNA test to be offered to all cancer patients
The annual report by Prof Dame Sally Davies says that the genomic plan should be implemented within 5 years in the NHS
-
5-ALA gets FDA approval
The United States’ Food and Drug Administration (FDA) has approved the use of aminolevulinic acid hydrochloride as an optical imaging agent for use in people affected by high grade gliomas.
-
Aykroyd & Sons’s toughest challenge yet
Aykroyd & Son’s recently completed the Three Peaks challenge in less than 24 hours, raising £5000!
-
Vote for HeadSmart!
HeadSmart is a finalist in the National Lottery Awards ‘Best Health Project’ category
-
Researchers develop a probe that helps detect cancers cells with almost 100% accuracy
A probe that was first developed by researchers in Canada in 2015 has since been perfected by the team
-
Launching The Everest Centre for research into childhood brain tumours
A groundbreaking international centre for research into childhood brain tumours will be launched today (June 27) in London
-
Scientists have discovered that a lack of ‘editing’ could be driving the most aggressive brain tumours
A new study from the CSIR-Institute of Genomics and Integrative Biology in India examined the mechanism of gene expression within brain tumours and found a lack of microRNA editing
-
Scientists have discovered a protein that could potentially predict glioblastoma outcomes
Scientists from the Cancer Science Institute of Singapore at the National University of Singapore have discovered that the protein BCL6 could potentially be used as a marker to predict the clinical outcome of patients with glioblastoma
-
General Election 2017 result: No overall majority as Labour make unexpected gains
After seven weeks of relentless political campaigning across the UK, voters finally had their say at polling booths on Thursday, as a shock ‘hung parliament’ result emerged
-
Researchers from the University of Ohio have found changes in blood that are detectable five years before the diagnosis of brain cancer
A study conducted by Judith Schwartzbaum from the University of Ohio has found that changes in the immune systems appear to signal brain cancer 5 years before symptoms arise
-
Scientists discover enzyme that supports brain tumour growth
Researchers from the University of Texas MD Anderson have discovered an enzyme that helps brain tumours grow in nutrient-starved environments
-
Proud to be part of the launch of Less Survivable Cancers Taskforce
Yesterday saw the launch of the Less Survivable Cancers Taskforce to an audience of members of the Scottish Parliament in Holyrood, Edinburgh
-
Could the Zika virus be used to treat glioblastomas?
The University of Cambridge is to begins trials using the Zika virus on glioblastoma, the most common and aggressive form of brain tumour. Glioblastomas affect 2,200 people in the UK each year
-
New insight into medulloblastoma
The most common type of malignant childhood brain cancer has been identified as seven separate conditions each needing a different treatment, new research has revealed.